Search Results - "Andrews, Meghan K."

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models by Cox, Robert M., Lieber, Carolin M., Wolf, Josef D., Karimi, Amirhossein, Lieberman, Nicole A. P., Sticher, Zachary M., Roychoudhury, Pavitra, Andrews, Meghan K., Krueger, Rebecca E., Natchus, Michael G., Painter, George R., Kolykhalov, Alexander A., Greninger, Alexander L., Plemper, Richard K.

“…Therapeutic options against SARS-CoV-2 are underutilized. Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), have received emergency use…”
Get full text

Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets by Cox, Robert M., Wolf, Josef D., Lieberman, Nicole A., Lieber, Carolin M., Kang, Hae-Ji, Sticher, Zachary M., Yoon, Jeong-Joong, Andrews, Meghan K., Govindarajan, Mugunthan, Krueger, Rebecca E., Sobolik, Elizabeth B., Natchus, Michael G., Gewirtz, Andrew T., deSwart, Rik L., Kolykhalov, Alexander A., Hekmatyar, Khan, Sakamoto, Kaori, Greninger, Alexander L., Plemper, Richard K.

“…Measles cases have surged pre-COVID-19 and the pandemic has aggravated the problem. Most measles-associated morbidity and mortality arises from destruction of…”
Get full text

Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV‑2 Mpro Inhibitors by Jacobs, Leon, van der Westhuyzen, Aletta, Pribut, Nicole, Dentmon, Zackery W., Cui, Dan, D’Erasmo, Michael P., Bartsch, Perry W., Liu, Ken, Cox, Robert M., Greenlund, Sujay F., Plemper, Richard K., Mitchell, Deborah, Marlow, Joshua, Andrews, Meghan K., Krueger, Rebecca E., Sticher, Zachary M., Kolykhalov, Alexander A., Natchus, Michael G., Zhou, Bin, Pelly, Stephen C., Liotta, Dennis C.

“…The SARS-CoV-2 main protease (Mpro) has been proven to be a highly effective target for therapeutic intervention, yet only one drug currently holds FDA…”
Get full text

Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M pro Inhibitors by Jacobs, Leon, van der Westhuyzen, Aletta, Pribut, Nicole, Dentmon, Zackery W, Cui, Dan, D'Erasmo, Michael P, Bartsch, Perry W, Liu, Ken, Cox, Robert M, Greenlund, Sujay F, Plemper, Richard K, Mitchell, Deborah, Marlow, Joshua, Andrews, Meghan K, Krueger, Rebecca E, Sticher, Zachary M, Kolykhalov, Alexander A, Natchus, Michael G, Zhou, Bin, Pelly, Stephen C, Liotta, Dennis C

“…The SARS-CoV-2 main protease (M ) has been proven to be a highly effective target for therapeutic intervention, yet only one drug currently holds FDA approval…”
Get full text